Posted by Michael Wonder on 02 Nov 2022
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis
2 November 2022 - NICE is unable to make a recommendation on slow-release potassium bicarbonate–potassium citrate (Sibnayal) for treating distal renal tubular acidosis in people 1 year and over.
This is because Advicenne withdrew its evidence submission. NICE will review this decision if Advicenne decides to make a submission.
